Australian researchers have have discovered a non-invasive ultrasound technology that helps in clearing the brain of neurotoxic amyloid plaques – structures that are the main cause of memory loss and a decline in cognitive function that is apparent in Alzheimer’s patients.
Alzheimer’s is usually the result of a build-up of two types of lesions – amyloid plaques, and neurofibrillary tangles. Amyloid plaques that house between the neurons, end up forming dense clusters of beta-amyloid molecules which is a sticky kind of protein which clumps together and forms plaques.
Neurofibrillary tangles are seen inside the neurons of the brain. They are caused by defective tau proteins that clump up into a thick, insoluble mass. This causes tiny filaments that are known as microtubules that get all twisted, and this disrupts the transportation of essential materials like nutrients and organelles along them.
As we don’t possess any kind of vaccine or preventative measure against Alzheimer’s – a disease that affects more than 340,000 people in Australia, and 50 million people worldwide – it’s been a contest to figure out how to treat it the best, beginning with how to clear the dangerous build-up of defective beta-amyloid and tau proteins from a patient’s brain. There is a team from the Queensland Brain Institute (QBI) at the University of Queensland that has come up with a pretty promising solution to remove the former.
Publishing in Science Translational Medicine, the team explains the technique using a particular type of ultrasound called a focused therapeutic ultrasound, which non-invasively beams sound waves into the brain tissue. By oscillating super-fast, these sound waves enable the blood brain barriers to open, which is a layer that protects the brain against bacteria, and stimulate the brain’s microglial cells to activate. Microglila cells are basically waste-removal cells, so they’re able to clear out the toxic beta-amyloid clumps that are responsible for the worst symptoms of Alzheimer’s.



